Moderna, Inc. (MRNA) Down 35% YTD. Here Is Why
Moderna, Inc. (NASDAQ:MRNA) is among the 13 Best S&P 500 Stocks to Buy According to Wall Street Analysts, based on upside potential.
Moderna Inc. (MRNA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Theleme Partners Patrick Degorce | 7,868,810 | $217,100,468 | +9% | 13.2% |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 7,815,700 | $215,635,163 | +106% | 0.44% |
| 3. | D E Shaw D. E. Shaw | 7,463,555 | $205,919,482 | +33% | 0.15% |
| 4. | 4,698,200 | $129,623,338 | +20% | 0.02% | |
| 5. | 4,197,400 | $115,806,266 | -15% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $31.53 | 57,493 | $1,812,754.29 | 9,210,686 | 2025-03-03 | Filing | |
| $31.04 | 102,821 | $3,191,563.84 | 9,153,193 | 2025-03-03 | Filing | |
| $31.76 | 31,620 | $1,004,251.20 | 312,027 | 2025-03-03 | Filing | |
| $19.00 | 52,631 | $999,989.00 | 420,407 | 2020-02-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $28.00 | 312 | $8,736.00 | 580 | 2025-06-11 | Filing | |
| $44.68 | 529 | $23,637.31 | 20,446 | 2024-12-09 | Filing | |
| $43.30 | 112 | $4,849.28 | 19,837 | 2024-12-03 | Filing | |
| $43.30 | 314 | $13,595.29 | 1,443,904 | 2024-12-03 | Filing | |
| $42.79 | 1,420 | $60,760.52 | 11,066 | 2024-11-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 41,708,705 | $1,150,743,171 | 0.02% | |
| 2. | 28,611,470 | $789,390,449 | 0.02% | |
| 3. | 22,094,124 | $609,576,880 | 0.46% | |
| 4. | 19,645,464 | $542,018,354 | 0.03% | |
| 5. | 17,270,631 | $476,496,709 | 0.02% |
News See All
11 Best Cancer Stocks to Buy Right Now
Cancer remains the second leading cause of death globally, after heart disease.
13 Best S&P 500 Stocks to Buy According to Wall Street Analysts
The S&P 500 index dipped 0.24% to close at 6,395.78 on Wednesday, marking its fourth successive day of losses, sparked by an ongoing tech sell-off.
Moderna, Inc. (MRNA)'s "Got The Double Whammy," Says Jim Cramer
Moderna, Inc. (NASDAQ:MRNA) has been one of the most ill-fated stocks in 2025.
10 Stocks Jim Cramer Mentioned As He Talked About "Love Lost" Between Microsoft & OpenAI
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the relationship between Microsoft and OpenAI.
Moderna, Inc. (NASDAQ:MRNA) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to Moderna's Second Quarter 2025 Conference Call. [Operator Instructions]. Please be advised today's conference is being recorded.
Moderna (MRNA) Jumps 8.8% on COVID-19 Support from Medical Organizations
Moderna Inc. jumped by 8.83 percent on Tuesday to close at $32.54 apiece as investor sentiment was boosted by a lawsuit filed against Health Secretary Robert F. Kennedy Jr.
Moderna, Inc. (MRNA): A Bull Case Theory
We came across a bullish thesis on Moderna, Inc. (MRNA) on Natan’s Substack. In this article, we will summarize the bulls’ thesis on MRNA. Moderna, Inc.
Moderna RSV Vaccine Gains Expanded FDA Approval for Younger Adults
Moderna Inc. (NASDAQ:MRNA) is one of the best mid cap growth stocks to invest in now.
11 Best Mid Cap Growth Stocks To Invest In Now
On June 18, Scott Wren, Wells Fargo senior global market strategist, joined CNBC's 'Closing Bell Overtime' to talk about how the market sell-off is an opportunity to step in.